93 293 (Carbidopa and levodopa 25 mg / 100 mg)

Pill imprint 93 293 has been identified as Carbidopa and levodopa 25 mg / 100 mg.

Carbidopa/levodopa is used in the treatment of parkinson's disease; restless legs syndrome; neuroleptic malignant syndrome; gtp-ch deficiency and belongs to the drug class dopaminergic antiparkinsonism agents. Risk cannot be ruled out during pregnancy. Carbidopa/levodopa 25 mg / 100 mg is not subject to the Controlled Substances Act.

See also related documents.

Images for 93 293 (Carbidopa and levodopa 25 mg / 100 mg)

Carbidopa and levodopa 25 mg / 100 mg 93 293  Front
Carbidopa and levodopa 25 mg / 100 mg 93 293  Back
Carbidopa and levodopa
93 293
25 mg / 100 mg
9.00 mm
Prescription only
Drug Class:
Dopaminergic antiparkinsonism agents
Pregnancy Category:
C - Risk cannot be ruled out
CSA Schedule:
N - Not a controlled drug
Teva Pharmaceuticals USA
National Drug Code (NDC):
Inactive Ingredients:
magnesium stearate
microcrystalline cellulose
corn starch
D&C Yellow No. 10
FD&C Yellow No. 6

View Details Print Page

Pill Identifier

Search by Imprint, Shape or Color

Note: All fields are optional. Use the pill finder to identify medications by visual appearance or name. All Rx and OTC drugs in the US are required by the FDA to have an imprint. If your pill has no imprint it could be a vitamin, diet/herbal/energy pill, illicit or foreign drug. More about imprint codes...

Search by Drug Name

Search by National Drug Codes (NDC)

Learn how medication, diet, and exercise are key to managing Multiple Sclerosis. Click Here